Asset
Dasminapant
Ascentage Pharma Group International American Depository Shares
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04568265 | phase2 | unknown | 2020-06-03 | 2022-10-31 | Ascentage Pharma Group Inc. | A Clinical Study of APG-1387 in Combination With Entecavir in Patients With Chronic Hepatitis B |
FDA applications (0)
This company has no applications containing this asset.